USPTO Extends Director Review Option to Institution Decisions, Retires the Precedential Opinion Panel, and Updates Interim DR Procedures
July 31, 2023
Authored and Edited by Yinan Liu, Ph.D.; David C. Reese; Stacy Lewis†
Effective July 24, 2023, the USPTO revised its procedures for the interim Director Review (DR) of PTAB decisions, including:
- Expanding the process to permit parties to request DR of PTAB decisions on institution in AIA proceedings;
- Providing updated guidance as to what types of issues the Director will consider in DR, as well as additional guidance on various topics, such as the initiation of DR at the sole discretion of the Director (sua sponte DR), remands to PTAB for further proceedings, and sanction authority of the Director;
- Providing the Director the option to delegate review to a new independent panel called the Delegated Rehearing Panel (DRP); and
- Creating a new Appeals Review Panel (ARP) to review PTAB ex parte, reexamination, or reissue appeal decisions.
For an in-depth discussion of the revised interim process, click here.
Tags
United States Patent and Trademark Office (USPTO), Precedential Opinion Panel (POP), Patent Trial and Appeal Board (PTAB)
Related Offices
Contacts
- Yinan Liu, Ph.D.
- Associate
- Boston, MA
- +1 617 646 1652
†Stacy Lewis is a Law Clerk at Finnegan.
Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.